Ms. Devers is our executive vice president and chief human resources officer. Ms. Devers joined Ionis in February 2001 as a senior human resources manager and as a director assumed full responsibility for human resources and campus operations in 2006. In 2020, as Senior Vice President, Ms. Devers expanded her scope to include our facilities organization.
Ms. Devers has been an integral part of Ionis for over two decades, demonstrating strong leadership and strategic insight in the field of Human Resources. Before joining Ionis, Ms. Devers gained valuable HR experience in roles at Target Corporation, Nike, Inc., and Taco Bell Corporation.
Ms. Devers has played a critical role in shaping Ionis’ company culture, driving organizational change, fostering innovation, and focusing on environmental sustainability. She has provided strategic guidance to align HR and Facilities initiatives with the organization’s overall goals and objectives. She has been instrumental in shaping and reinforcing the company's culture and core principles, facilitating internal training programs, and spearheading initiatives to enhance employee integration, engagement, and retention. Her strategic vision and operational expertise have contributed to Ionis’ growth and success.
Ms. Devers holds a Master of Business Administration in Human Resource Management and Marketing from the University of Florida and a Bachelor of Science in Business Administration, cum laude, with a focus on Marketing from the University of Central Florida.
What is Shannon L. Devers' net worth?
The estimated net worth of Shannon L. Devers is at least $1.43 million as of November 25th, 2025. Ms. Devers owns 17,494 shares of Ionis Pharmaceuticals stock worth more than $1,431,184 as of December 5th. This net worth estimate does not reflect any other investments that Ms. Devers may own. Learn More about Shannon L. Devers' net worth.
How do I contact Shannon L. Devers?
Has Shannon L. Devers been buying or selling shares of Ionis Pharmaceuticals?
In the last ninety days, Shannon L. Devers has sold $1,888,049.13 of Ionis Pharmaceuticals stock. Most recently, Shannon L. Devers sold 16,777 shares of the business's stock in a transaction on Tuesday, November 25th. The shares were sold at an average price of $80.91, for a transaction totalling $1,357,427.07. Following the completion of the sale, the executive vice president now directly owns 17,494 shares of the company's stock, valued at $1,415,439.54. Learn More on Shannon L. Devers' trading history.
Who are Ionis Pharmaceuticals' active insiders?
Ionis Pharmaceuticals' insider roster includes Joseph Baroldi (EVP & Chief Business Officer), C. Bennett (EVP), Spencer Berthelsen (Director), Brian Birchler (EVP), Onaiza Cadoret-Manier (EVP), Breaux Castleman (Director), Stanley Crooke (Chairman), Shannon Devers (Executive Vice President, Chief Human Resources Officer), Allene Diaz (Director), Richard Geary (EVP), Michael Hayden (Director), Elizabeth Hougen (CFO), Joseph Klein, III (Director), Brett Monia (CEO), Frederick Muto (Director), Patrick O'Neil (EVP), B. Parshall, Esq. (Director), Eugene Schneider (EVP), Eric Swayze (EVP), and Joseph Wender (Director). Learn More on Ionis Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Ionis Pharmaceuticals?
During the last year, Ionis Pharmaceuticals insiders bought shares 2 times. They purchased a total of 20,000 shares worth more than $659,000.00. During the last year, insiders at the sold shares 59 times. They sold a total of 1,110,343 shares worth more than $67,968,421.56. The most recent insider tranaction occured on December, 1st when Director Joseph H Wender sold 28,000 shares worth more than $2,262,960.00. Insiders at Ionis Pharmaceuticals own 2.6% of the company.
Learn More about insider trades at Ionis Pharmaceuticals. Information on this page was last updated on 12/1/2025.
